Use of Patented Products for International Humanitarian Purposes Regulations

Version of section 11 from 2006-03-22 to 2018-06-24:

 For the purpose of paragraph (b) of the definition average price in subsection 21.17(6) of the Act, the publications reporting the prices in Canada of pharmaceutical products sold by or with the consent of the patentee that are equivalent to the pharmaceutical product to which an authorization under section 21.04 of the Act relates are the following:

  • (a) the Ontario Drug Benefit Formulary, as amended from time to time;

  • (b) the Drug Formulary published by the Régie de l’assurance maladie du Québec, as amended from time to time; and

  • (c) the PPS® Pharma Publication published by Total Pricing Systems Inc., as amended from time to time.

Date modified: